Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Ultomiris approved in EU for gMG
Investegate announcements from AstraZeneca PLC, Ultomiris approved in EU for gMG
Stay updated with breaking news from Efficacy Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from AstraZeneca PLC, Ultomiris approved in EU for gMG
23.09.2022 - FREEMONT, CA, Sept. 23, 2022 (GLOBE NEWSWIRE) - via NewMediaWire - ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced ... Seite 1
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
31.08.2022 - DEVON, Pa., Aug. 31, 2022 (GLOBE NEWSWIRE) - Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today announced the acceptance ... Seite 1
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires